Abstract
This summary article provides an update on novel clinical trials in the field of cardiovascular (CV) medicine which were presented at the Transcatheter Cardiovascular Therapeutics meeting, held in San Francisco in September 2009. The data were presented by leading experts in the field with relevant positions in the trials and registries. Unpublished reports should be considered as preliminary data as the analysis may change in the final publications. This article provides the reader with comprehensive summaries of the most recent diagnostic and therapeutic developments in CV medicine.
Similar content being viewed by others
References
Maier LS, Baumhäkel M, Bohm M (2009) Hotline sessions presented at the American College of Cardiology Congress 2009. Clin Res Cardiol 98(6):345–352
Müller P, Rosenkranz S, Adam O, Custodis F, Böhm M (2008) Clinical trial updates and hotline sessions presented at the European Society of Cardiology Congress 2008. Clin Res Cardiol 97(12):851–864
Möllmann H, Nef H, Böhm M, Laufs U (2009) Highlights of the hotline sessions presented at the scientific sessions 2008 of the American Heart Association. Clin Res Cardiol 98(1):1–7
Windecker S, Remondino A, Eberli FR et al (2005) Sirolimus-eluting and paclitaxel-eluting stents for coronary revascularization. N Engl J Med 353(7):653–662
Windecker S, Serruys PW, Wandel S et al (2008) Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial. Lancet 372(9644):1163–1173
Tonino PA, De Bruyne B, Pijls NH et al (2009) Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. N Engl J Med 360(3):213–224
Wallentin L, Becker RC, Budaj A et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045–1057
Krum H, Schlaich M, Whitbourn R et al (2009) Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 373(9671):1275–1281
Stone GW, Lansky AJ, Pocock SJ et al (2009) Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction. N Engl J Med 360(19):1946–1959
Mehran R, Lansky AJ, Witzenbichler B et al (2009) Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial. Lancet 374(9696):1149–1159
Author information
Authors and Affiliations
Corresponding author
Additional information
H. Möllmann and H. M. Nef contributed equally.
Rights and permissions
About this article
Cite this article
Möllmann, H., Nef, H.M., Hamm, C.W. et al. Highlights from Transcatheter Cardiovascular Therapeutics 2009. Clin Res Cardiol 98, 811–817 (2009). https://doi.org/10.1007/s00392-009-0090-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00392-009-0090-5